ERBB2 and breast cancer: Hence, in this study, we use a mathematical modeling-based approach to develop a new model and quantify the growth inhibition of HER2+ BC cell colonies (ZR75) when treated with anti-HER2 (TZ) and anti-PD-1/PD-L1 (BMS-202) agents.